Table 3.
The serologic parameters in Placebo and J . regia treated groups (mean ± SD)
| |
J
.
regia
(n = 30) |
Placebo (n = 28) |
|
||||
|---|---|---|---|---|---|---|---|
| Beginning | After 2 month | p -value | Beginning | After 2 month | p -value | P -value Difference of difference | |
| FBS (mg/d L) |
165 ± 54 |
144 ± 65 |
0.017 |
169 ± 71 |
171 ± 61 |
0.847 |
0.079 |
| HbA1c (%) |
8.5 ± 1.6 |
7.6 ± 1.3 |
0.000 |
8.3 ± 1.7 |
7.7 ± 1.5 |
0.042 |
0.068 |
| Insulin (U/L) |
8.6 ± 4.2 |
10.4 ± 4.7 |
0.007 |
8.6 ± 3.6 |
9.1 ± 3.9 |
0.413 |
0.138 |
| SGOT (U/L) |
11.6 ± 5.3 |
12.6 ±5.0 |
0.293 |
12.5 ± 4.2 |
12.2 ± 4.5 |
0.110 |
0.879 |
| SGPT (U/L) |
8.7 ± 3.7 |
9.7 ± 2.9 |
0.849 |
9.5 ± 3.1 |
8.5 ± 2.8 |
0.708 |
0.692 |
| ALP (IU/L) | 159 ± 30 | 163 ±43 | 0.469 | 152 ± 59 | 152 ± 46 | 0.228 | 0.660 |
HbA1c (%).
8.5% NGSP = 70 mmol/mol IFCC = 198 mg/dL eAG.
7.6% NGSP = 60 mmol/mol IFCC = 171 mg/dL eAG.
8.3% NGSP = 67 mmol/mol IFCC = 191 mg/dL eAG.
7.9% NGSP = 62 mmol/mol IFCC = 179 mg/dL eAG.